|
|
Post by whanley7 on Nov 6, 2015 2:57:10 GMT -5
Talking about toujeo now
|
|
|
|
Post by esstan2001 on Nov 6, 2015 2:57:24 GMT -5
That is the bone they throw us? I hope it is true, but my belief is quite shaken.
|
|
|
|
Post by jpg on Nov 6, 2015 2:58:16 GMT -5
Toujeo early progress and helped stabilize Lantus loss. 3 real world study then phase 3b and new pen
Praluent: awareness, Europe on the way.
Dengue vaccine
|
|
|
|
Post by mbracket1234 on Nov 6, 2015 2:58:59 GMT -5
Key data point - there are many drugs they didnt mention by name. But, they didnt throw under the bus.
|
|
|
|
Post by jpg on Nov 6, 2015 2:59:26 GMT -5
Lexilan is great or something like that
|
|
|
|
Post by jpg on Nov 6, 2015 2:59:41 GMT -5
R and D pipeline
|
|
|
|
Post by jpg on Nov 6, 2015 3:00:14 GMT -5
For some reason I don't like this guy?
|
|
|
|
Post by kdaddyfresh2000 on Nov 6, 2015 3:01:32 GMT -5
Key data point - there are many drugs they didnt mention by name. But, they didnt throw under the bus. No, the-throw-under-the-bus occurred a few days ago at the CC. |
|
|
|
Post by esstan2001 on Nov 6, 2015 3:01:42 GMT -5
Brandencourt?
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 6, 2015 3:05:12 GMT -5
I would start with Sanofi's global distribution network, and as one of the giant BP's of the world, has the ability to make Afrezza the game-changer that Al Mann envisions. There's that.
But, it's going to be a long road which is why I call this an investment.
|
|
|
|
Post by benyiju on Nov 6, 2015 3:06:24 GMT -5
Scripts better be 1000+ tomorrow...
|
|
|
|
Post by whanley7 on Nov 6, 2015 3:07:12 GMT -5
I would start with Sanofi's global distribution network, and as one of the giant BP's of the world, has the ability to make Afrezza the game-changer that Al Mann envisions. There's that. But, it's going to be a long road which is why I call this an investment. MNKD will be bankrupt within 1-2 years without significant dilution or Afrezza not generating positive cash flow. |
|
|
|
Post by lakers on Nov 6, 2015 3:08:20 GMT -5
Selective, Disciplined M&A
|
|
|
|
Post by kdaddyfresh2000 on Nov 6, 2015 3:09:27 GMT -5
I would start with Sanofi's global distribution network, and as one of the giant BP's of the world, has the ability to make Afrezza the game-changer that Al Mann envisions. There's that. But, it's going to be a long road which is why I call this an investment. The point is, is that SNY is not doing anything to sell Afrezza despite being a huge BP. Not one mention. Not one. This week has been a real eye-opener and slap in the face. |
|
|
|
Post by benyiju on Nov 6, 2015 3:11:34 GMT -5
I definitely do feel slapped in ze face, but scripts COULD come in 1000+ tomorrow...
|
|
